Racial Differences Seen in Prostate Cancer Care Quality

Follow Drugslib on

By Lori Solomon HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

WEDNESDAY, July 30, 2025 -- Black men with newly diagnosed prostate cancer have lower odds of overtreatment and confirmatory testing when compared with White men, according to a research letter published online July 24 in JAMA Network Open.

Dawson C. Hill, from the University of Michigan in Ann Arbor, and colleagues examined racial differences in confirmatory testing and potential overtreatment in men with newly diagnosed prostate cancer. The analysis included 8,051 men electing for active surveillance and 5,090 unhealthy men at risk for overtreatment identified from a sample of Medicare beneficiaries (2014 to 2019).

The researchers found that Black race was associated with lower odds of undergoing confirmatory testing within 12 months of diagnosis versus White race (adjusted odds ratio, 0.75), yielding a 6.1 percent decrease in confirmatory testing completion. Black race was associated with lower odds of overtreatment among unhealthy men (adjusted odds ratio, 0.86) compared with White race. Overtreatment was less common in Black men versus White men (adjusted difference, 6.1 percent).

"Our study highlights the importance of understanding the nuanced relationship between utilization and prostate cancer care quality when trying to improve care for underserved communities," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-07-31 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords